drugset / Trial / NCT02980198

Study of IFN-K in Dermatomyositis

NCT02980198 ↗

Phase 2 Withdrawn Neovacs
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a Proof of Concept study aiming to evaluate the production of anti-IFNα antibodies (immune response) in adult subjects with dermatomyositis

Timeline

Start
2017-05-03
Primary completion
2019-12-11
Completion
2019-12-11

Outcome

Outcome not reported

Stopped: “reorganization proceedings with a potential risk of company liquidation”

Drugs

EvaluationDrugModalityDoseRoute
Subject IFN-Kinoid Unknown — Intramuscular

Indications